Home/Filings/4/0001209191-23-021531
4//SEC Filing

Hirmand Mohammad 4

Accession 0001209191-23-021531

CIK 0001422142other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:20 PM ET

Size

6.0 KB

Accession

0001209191-23-021531

Insider Transaction Report

Form 4
Period: 2023-03-27
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-27+59,20659,206 total
    Exercise: $7.25Exp: 2033-03-27Common Stock (59,206 underlying)
Footnotes (1)
  • [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to option shall be fully vested on the three year anniversary of the grant date. The grant date is March 27, 2023.

Issuer

Aadi Bioscience, Inc.

CIK 0001422142

Entity typeother

Related Parties

1
  • filerCIK 0001654482

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:20 PM ET
Size
6.0 KB